All News

Your weekly roundup of the latest news from Drug Topics®.

Relocation led to a reduction in asthma exacerbations, exceeding the effect of inhaled corticosteroids, and was similar to biologic agents.

Researchers found a significant decrease in mortality or discharge to hospice with the hydrocortisone-fludrocortisone combination versus hydrocortisone alone in septic shock cases.

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Health plans must continue providing free screenings pending court’s further consideration of case.

Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.

How much progress have we made in developing therapies to treat this common childhood respiratory disorder?

Following some improvement, excess death rate returned to 1999 levels for Black men and 2005 levels for Black women.

The REFLECT Scoliosis Correction System from Globus Medical is intended to correct progressive scoliosis in pediatric patients while simultaneously maintaining stability and motion as well as allowing for future modulated growth.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

Doing small spurts of exercise throughout the day provide numerous benefits.

What can CGM's provide for individuals who don't have diabetes?

Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.

Using a national database, data on medication purchases was collected, along with factors that may have influenced expenditures, such as new therapy availability, patent expirations, policy changes, and legislation.

The company that developed the treatment said it will benefit "millions" of patients.

Data from two phase 3 studies showed that brexpiprazole 2 mg or 3 mg doses significantly improved symptoms of agitation in patients with AAD.

Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.

There are only a few long-term treatments currently available for adolescents with moderate to severe AD.

Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.

Common treatments for acne are known to be unsafe for pregnant women, but alternative treatments exist that are safe for use; however, actual treatment patterns within this patient population are unclear.

A new CDC report on data collected by the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy, indicates that medication for opioid use disorder is more often given to individuals who are White, older, and have private insurance.

The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.

Inhaled corticosteroids were observed to be associated with increases in rates of pneumonia and tuberculosis, according to a recent study.

A new study investigates whether GPT-4 can provide more in-depth analysis than medical professionals.

WHO ends COVID-19 public health emergency, privacy concerns around mental health apps, and astronomical interest with medical credit cards.

A recent clinical trial showed positive results from the selective neurokinin-1,3 receptor antagonist elinzanetant (Bayer) against menopausal vasomotor symptoms.